Form 4: HealthEquity Director Stuart B. Parker Reports Acquisition and Disposal of Common Stock

Director Stuart B. Parker reports acquiring 2,543 shares of HealthEquity, Inc. common stock and disposing of an unspecified amount on July 5, 2024.

Summary

• On July 5, 2024, Stuart B. Parker, a director of HealthEquity, Inc., reported a transaction involving the company's common stock.
• Parker acquired 2,543 shares of common stock at a price of $0.
• Parker also disposed of an unspecified amount of common stock.
• Following the reported transactions, Parker beneficially owns 44,061 shares of HealthEquity, Inc.
• The 2,543 shares were acquired in the form of restricted stock units, which vest in full on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting.
• Vested shares will be delivered to the reporting person on February 1, 2028.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral. It simply reports transactions by a company insider.

Future Outlook

The restricted stock units vest in full on the earlier of July 5, 2025 or the date of the issuer's next annual stockholder meeting, with vested shares delivered on February 1, 2028.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is a common practice in publicly traded companies to ensure transparency and prevent insider trading.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine disclosure of insider trading activity.
• It provides transparency to shareholders regarding the actions of company directors.

Key Dates